A LifeVac is a handheld suction device designed to dislodge food or objects stuck in someone’s airway during a choking emergency. It consists of three simple parts: a face mask, a plunger (compressible bellows), and a one-way valve. The FDA classifies it as a Class II medical device and specifically designates it as a “suction anti-choking device” intended for use only after standard choking rescue techniques have failed.
How the LifeVac Works
The device creates suction to pull a stuck object upward and out of the airway. You place the mask over the choking person’s mouth and nose to form a seal, push the plunger down, then pull it back up. The one-way valve is the key design element: it prevents air from being pushed into the person’s airway on the downward push, and generates negative pressure (suction) on the upward pull. That suction is meant to dislodge whatever is blocking the airway.
Each LifeVac is single-use. Once the plunger has been deployed, the device cannot be reused on another occasion. Kits come with two mask sizes: a pediatric mask recommended for children 22 pounds and up, and an adult mask. The manufacturer does not specify a maximum weight for the pediatric mask or a minimum weight for the adult one, so there’s a gray area in between where parents will need to judge which mask creates a better seal on the child’s face.
FDA Classification and Regulatory Status
The FDA granted the LifeVac a De Novo classification, placing it into Class II under regulation number 21 CFR 874.5400. This is important context: Class II means the FDA considers the device to pose moderate risk and requires certain controls, but it is not the same as full clinical approval. The classification specifically labels it a “second-line treatment,” meaning it is intended for use only after established choking protocols have already been attempted without success.
The FDA has issued a safety communication reinforcing this point. The agency encourages the public to always follow choking rescue protocols approved by the American Red Cross and the American Heart Association before turning to any device. Those standard techniques, back blows and abdominal thrusts (the Heimlich maneuver), have a high success rate and can be performed immediately without needing to locate, unpackage, or assemble a device.
What the Evidence Actually Shows
LifeVac has been discussed in several peer-reviewed journals, including the American Journal of Emergency Medicine and Resuscitation, but the published evidence is limited in scope. Most studies fall into a few categories: cadaver tests, mannequin trials, and individual case reports rather than large-scale clinical trials on living patients.
A cadaver study published in a peer-reviewed journal tested the LifeVac against different types of foreign bodies and found mixed results. The device successfully removed soft, moist obstructions (barium-moistened crackers) but failed to remove all other types of foreign bodies tested. That’s a meaningful limitation, because real-world choking involves a wide variety of foods and objects with different shapes, textures, and levels of stickiness.
The published literature also includes anecdotal case reports describing successful uses. These are individual stories, not controlled studies, so they demonstrate that the device can work in some situations but don’t establish a reliable success rate. No large, randomized study has compared LifeVac head-to-head with standard choking techniques in actual emergencies.
Where It Fits With Standard Choking Response
Both the American Red Cross and the American Heart Association have established choking rescue protocols that remain the recommended first response. For a conscious adult or child over one year old, that means alternating between back blows and abdominal thrusts. For infants, it’s back slaps and chest thrusts. These techniques require no equipment, no setup time, and have decades of evidence behind them.
The FDA’s position is clear: these standard methods should always come first. A LifeVac is positioned as a backup, something to reach for if multiple rounds of back blows and abdominal thrusts have not cleared the obstruction and the person is still choking. In that narrow scenario, having an additional option could matter, particularly for people who lack the physical strength to perform effective abdominal thrusts, such as elderly caregivers or those with disabilities.
Practical Considerations Before Buying
LifeVac kits typically cost between $70 and $100. Because the device is single-use, you’ll need to purchase a replacement after each deployment, even if it was used for practice or opened by mistake. The device has a shelf life, so it’s worth checking expiration dates if it sits unused for a long time.
The biggest practical concern is accessibility during an emergency. Choking events escalate fast. A person with a completely blocked airway can lose consciousness within minutes. If the device is stored in a closet, still in its packaging, the time spent finding and assembling it is time not spent performing abdominal thrusts or back blows. For families who choose to keep one on hand, storing it somewhere immediately accessible and familiarizing yourself with its use beforehand makes it far more likely to be useful if the moment ever comes.
Learning standard choking response techniques remains the single most important step you can take. A LifeVac is not a substitute for knowing how to perform back blows and abdominal thrusts. It’s a supplementary tool with limited but real evidence behind it, classified by the FDA as a second-line option for situations where everything else has already been tried.